Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CDP-choline is not protective in the SOD1-G93A mouse model of ALS.
Knippenberg S, Skripuletz T, Rath KJ, Thau N, Gudi V, Pul R, Körner S, Dengler R, Stangel M, Petri S. Knippenberg S, et al. Among authors: rath kj. Amyotroph Lateral Scler Frontotemporal Degener. 2013 May;14(4):284-90. doi: 10.3109/21678421.2012.745569. Epub 2013 Jan 4. Amyotroph Lateral Scler Frontotemporal Degener. 2013. PMID: 23286744
Intraspinal administration of human spinal cord-derived neural progenitor cells in the G93A-SOD1 mouse model of ALS delays symptom progression, prolongs survival and increases expression of endogenous neurotrophic factors.
Knippenberg S, Rath KJ, Böselt S, Thau-Habermann N, Schwarz SC, Dengler R, Wegner F, Petri S. Knippenberg S, et al. Among authors: rath kj. J Tissue Eng Regen Med. 2017 Mar;11(3):751-764. doi: 10.1002/term.1972. Epub 2015 Jan 2. J Tissue Eng Regen Med. 2017. PMID: 25641599
Analysis of the therapeutic potential of different administration routes and frequencies of human mesenchymal stromal cells in the SOD1G93A mouse model of amyotrophic lateral sclerosis.
Bursch F, Rath KJ, Sarikidi A, Böselt S, Kefalakes E, Osmanovic A, Thau-Habermann N, Klöß S, Köhl U, Petri S. Bursch F, et al. Among authors: rath kj. J Tissue Eng Regen Med. 2019 Apr;13(4):649-663. doi: 10.1002/term.2846. Epub 2019 Mar 20. J Tissue Eng Regen Med. 2019. PMID: 30811816
Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial.
Ludolph AC, Schuster J, Dorst J, Dupuis L, Dreyhaupt J, Weishaupt JH, Kassubek J, Weiland U, Petri S, Meyer T, Grosskreutz J, Schrank B, Boentert M, Emmer A, Hermann A, Zeller D, Prudlo J, Winkler AS, Grehl T, Heneka MT, Wollebæk Johannesen S, Göricke B; RAS-ALS Study Group. Ludolph AC, et al. Lancet Neurol. 2018 Aug;17(8):681-688. doi: 10.1016/S1474-4422(18)30176-5. Epub 2018 Jun 19. Lancet Neurol. 2018. PMID: 29934198 Clinical Trial.